✦ LIBER ✦

Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass

✍ Scribed by G. Fontés; B. Zarrouki; D. K. Hagman; M. G. Latour; M. Semache; V. Roskens; P. C. Moore; M. Prentki; C. J. Rhodes; T. L. Jetton; V. Poitout

Book ID: 105819946
Publisher: Springer
Year: 2010
Tongue: English
Weight: 318 KB
Volume: 53
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-010-1850-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pancreatic islets from cyclin-dependent

Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes

✍ N. Marzo; C. Mora; M. E. Fabregat; J. Martín; E. F. Usac; C. Franco; M. Barbacid 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 269 KB

Population impact of increased body mass

Population impact of increased body mass index and attenuated beta-cell function on worsening of glucose metabolism in subjects with normal glucose tolerance: a pilot study

✍ Yamauchi, Keishi; Oka, Rie; Yagi, Kunimasa; Hayashi, Kenshi; Kawashiri, Masa-aki 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 188 KB

Chronic administration of ezetimibe incr

Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes

✍ Soo Jin Yang; Jung Mook Choi; Lisa Kim; Byung-Joon Kim; Jin Hee Sohn; Won Jun Ki 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 471 KB

Four-year metabolic outcome of a randomi

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

✍ B. Keymeulen; M. Walter; C. Mathieu; L. Kaufman; F. Gorus; R. Hilbrands; E. Vand 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 216 KB